Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Ofloxacin 200mg/100ml solution for infusion bottles
0501120P0AAACAC
|
Ofloxacin (Systemic) | Ofloxacin | Infections | No data available |
|
Ofloxacin 250mg/5ml oral liquid
0501120P0AAAEAE
|
Ofloxacin (Systemic) | Ofloxacin | Infections | No data available |
|
Oftalmolosa Cusi Eritromicina 0.5% eye ointment
1103010I0BBAAAA
|
Oftalmolosa Cusi Eritromicina | Erythromycin | Eye | No data available |
|
Ogivri 150mg pdr for concentrate for inf vials
0801050ADBIABAA
|
Ogivri | Trastuzumab | Malignant Disease and Immunosuppression | No data available |
|
Ogivri 420mg pdr for concentrate for inf vials
0801050ADBIAAAE
|
Ogivri | Trastuzumab | Malignant Disease and Immunosuppression | No data available |
|
Oh'Care Lite testing strips
0601060D0ESAAA0
|
Oh'Care Lite (Reagent) | Glucose blood testing reagents | Endocrine System | No data available |
|
Oilatum Junior Flare-Up bath additive
1302011L0BEABAD
|
Oilatum Plus | Light liquid paraffin | Skin | No data available |
|
Oilatum lotion
130201000BBJXA0
|
Proprietary compound emollients | Other emollient preparations | Skin | No data available |
|
Oilatum Natural Repair cream
190205500BCMLA0
|
Proprietary compound preparation BNF 1902055 | Other toiletry preparations | Other Drugs and Preparations | No data available |
|
Oilatum Natural Repair face cream
190205500BCLWA0
|
Proprietary compound preparation BNF 1902055 | Other toiletry preparations | Other Drugs and Preparations | No data available |
|
Oily phenol 5% solution for injection 25ml vials
0107030P0AAAFAF
|
Phenol in oil | Phenol | Gastro-Intestinal System | No data available |
|
Oily phenol 5% solution for injection 2ml ampoules
0107030P0AAABAB
|
Phenol in oil | Phenol | Gastro-Intestinal System | No data available |
|
Olanzapine 15mg/5ml oral solution
040201060AABCBC
|
Olanzapine | Olanzapine | Central Nervous System | No data available |
|
Olanzapine 5mg/5ml oral suspension
040201060AABFBF
|
Olanzapine | Olanzapine | Central Nervous System | No data available |
|
Olanzapine 6.5mg/5ml oral suspension
040201060AABEBE
|
Olanzapine | Olanzapine | Central Nervous System | No data available |
|
Olanzapine 6mg/5ml oral suspension
040201060AABDBD
|
Olanzapine | Olanzapine | Central Nervous System | No data available |
|
Olaparib 100mg tablets
0801050BYAAABAB
|
Olaparib | Olaparib | Malignant Disease and Immunosuppression | No data available |
|
Olaparib 150mg tablets
0801050BYAAACAC
|
Olaparib | Olaparib | Malignant Disease and Immunosuppression | No data available |
|
Olaparib 50mg capsules
0801050BYAAAAAA
|
Olaparib | Olaparib | Malignant Disease and Immunosuppression | No data available |
|
Olatuton 10mg inj vials
0803043N0BCAAAE
|
Olatuton | Octreotide acetate | Malignant Disease and Immunosuppression | No data available |
|
Olbas Blackcurrant pastilles
120304000BBCYA0
|
Proprietary compound preparation BNF 1203040 | Other mouth wash, gargle and dentifrice preparations | Ear, Nose and Oropharynx | No data available |
|
Olbas Oil liquid
030800000BDBLA0
|
Proprietary compound preparation BNF 0308000 | Other aromatic inhalation preparations | Respiratory System | No data available |
|
Olbas pastilles
120304000BBBIA0
|
Proprietary compound preparation BNF 1203040 | Other mouth wash, gargle and dentifrice preparations | Ear, Nose and Oropharynx | No data available |
|
Olbas PowerFlu Plus Vitamin C tablets
0407010X0CVAAA0
|
Olbas (Paracetamol combined) | Paracetamol combined preparations | Central Nervous System | No data available |
|
Oldaram 150mg modified-release tablets
040702040BQABAD
|
Oldaram | Tramadol hydrochloride | Central Nervous System | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.